Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-28

Clinical Trial Update: Long-term Safety and Efficacy Extension Trial of Bimatoprost SR [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and efficacy extension trial of Bimatoprost SR for open-angle glaucoma and ocular hypertension; current status is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost SR (bimatoprost)

Snippet

Sponsor: AbbVie | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: ACTIVE_NOT_RECRUITING